Zhang Yang, Xu Jin-Bu, Xiao Yao, Ji Wan-Sheng, Shan Lian-Hai, Wan Lin-Xi, Zhou Xian-Li, Lei Yu, Gao Feng
Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, People's Republic of China.
West China School of Pharmacy, Sichuan University, Chengdu 610041, People's Republic of China.
J Nat Prod. 2023 Apr 28;86(4):939-946. doi: 10.1021/acs.jnatprod.2c01150. Epub 2023 Feb 21.
A series of new -aryl galantamine analogues (-) were designed and synthesized by modification of galantamine, using Pd-catalyzed Buchwald-Hartwig cross-coupling reaction in good to excellent yields. The cholinesterase inhibitory and neuroprotective activities of -aryl derivatives of galantamine were evaluated. Among the synthesized compounds, the 4-methoxylpyridine-galantamine derivative () (IC = 0.19 μM) exhibited excellent acetylcholinesterase inhibition activity, as well as significant neuroprotective effect against HO-induced injury in SH-SY5Y cells. Molecular docking, staining, and Western blotting analyses were performed to demonstrate the mechanism of action of . Derivative would be a promising multifunctional lead compound for the treatment of Alzheimer's disease.
通过对加兰他敏进行修饰,利用钯催化的布赫瓦尔德-哈特维希交叉偶联反应,设计并合成了一系列新型的 -芳基加兰他敏类似物(-),产率良好至优异。评估了加兰他敏的 -芳基衍生物的胆碱酯酶抑制和神经保护活性。在合成的化合物中,4-甲氧基吡啶-加兰他敏衍生物()(IC = 0.19 μM)表现出优异的乙酰胆碱酯酶抑制活性,以及对SH-SY5Y细胞中HO诱导损伤的显著神经保护作用。进行了分子对接、染色和蛋白质印迹分析以证明 的作用机制。衍生物 将是一种有前途的用于治疗阿尔茨海默病的多功能先导化合物。